Crinetics Pharmaceuticals Inc (CRNX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
33.39 +0.08 (+0.24%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 33.39 unch (unch) 16:02 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CRNX | SLNO | CPRX | ||
| Company | Crinetics Pharmaceuticals Inc | Soleno Therapeutics Inc | Catalyst Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 32.96 | 74.23 | 24.28 | ||
| High | 33.80 | 75.70 | 24.61 | ||
| Low | 32.83 | 73.08 | 24.01 | ||
| Last | 33.39 | 74.86 | 24.29 | ||
| Change | +0.08 | -0.41 | +0.01 | ||
| % Change | +0.24% | -0.54% | +0.04% | ||
| Volume | 662,900 | 701,800 | 942,100 | ||
| 20-Day Average Volume | 1,007,530 | 1,344,740 | 1,183,115 | ||
| Previous Close | 33.31 | 75.27 | 24.28 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 30.08 | 69.97 | 22.92 | ||
| 20-Day Raw Stochastic | 95.77% | 91.33% | 92.40% | ||
| 20-Day Relative Strength | 52.51% | 64.64% | 56.64% | ||
| Weighted Alpha | -31.18 | +42.81 | +58.40 | ||
| Today's Opinion | 64% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 64% Sell | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Sell | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.15% since 04/23/25 | +3.58% since 04/23/25 | +5.06% since 04/23/25 | ||
| Low | 31.68 on 04/25/25 | 71.20 on 04/24/25 | 22.90 on 04/25/25 | ||
| High | 33.80 on 04/30/25 | 76.56 on 04/29/25 | 24.61 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | -3.86% since 03/28/25 | +3.99% since 03/28/25 | -1.62% since 03/28/25 | ||
| Low | 24.10 on 04/09/25 | 57.01 on 04/09/25 | 20.40 on 04/09/25 | ||
| High | 34.54 on 03/31/25 | 76.56 on 04/29/25 | 24.61 on 04/30/25 | ||
| 3-Month | |||||
| %Chg | -17.06% since 01/30/25 | +50.20% since 01/30/25 | +4.74% since 01/30/25 | ||
| Low | 24.10 on 04/09/25 | 43.00 on 03/11/25 | 20.23 on 03/11/25 | ||
| High | 41.07 on 01/31/25 | 76.56 on 04/29/25 | 26.16 on 03/24/25 | ||
| 6-Month | |||||
| %Chg | -40.12% since 10/30/24 | +34.35% since 10/30/24 | +12.66% since 10/30/24 | ||
| Low | 24.10 on 04/09/25 | 41.50 on 01/15/25 | 19.15 on 01/08/25 | ||
| High | 62.53 on 11/14/24 | 76.56 on 04/29/25 | 26.16 on 03/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,118,782 | 3,756,575 | 2,961,165 | ||
| Shares Outstanding, K | 93,629 | 49,908 | 121,959 | ||
| Annual Sales | 1,040,000 | 0 | 491,730,000 | ||
| Annual Net Income | -298,410,000 | -175,850,000 | 163,890,000 | ||
| Last Quarter Sales | 0 | 0 | 141,820,000 | ||
| Last Quarter Net Income | -76,830,000 | -55,980,000 | 55,940,000 | ||
| 60-Month Beta | 0.37 | -2.29 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.88 on 02/27/25 | -1.27 on 02/27/25 | 0.70 on 02/26/25 | ||
| Latest Earnings Date | 05/08/25 | 05/07/25 | 05/07/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 11.70 | ||